UFP Technologies Announces Key Financial Results on August 4

Author: Owen Jenkins Updated: 07-29-2025 04:31 PM

UFP Technologies to Share Second Quarter Financial Insights

UFP Technologies, Inc. (NASDAQ: UFPT), a leader in developing and manufacturing single-use medical devices, is eager to update stakeholders on its financial performance. The company will report its earnings for the second quarter, which concluded on June 30, 2025, on a scheduled date of August 4, 2025. This announcement follows a continuous commitment to transparency and investor engagement in the medical device sector.

Upcoming Conference Call

The anticipated release of financial results will be accompanied by a conference call for investors and analysts. This call is set to take place on August 5, 2025, at 8:30 AM Eastern Time. Interested participants are encouraged to use the following details to join the call:

Toll-Free Number: 1-888-243-4451
International Dial-In: 1-412-542-4135

Access to the Conference and Replay

For those unable to attend the live discussion, a webcast of the conference call will be provided, along with additional materials. These can be accessed at the official UFP Technologies website. The replay will also be available on their Investor Relations webpage, ensuring that all stakeholders have the chance to catch up on critical updates at their convenience.

Introducing UFP Technologies, Inc.

UFP Technologies, Inc. plays a crucial role in the medical industry by providing specialized contract development and manufacturing services. As a valued partner to numerous top-tier medical device manufacturers, UFP Technologies focuses on producing single-use medical devices that are integral to various medical fields. Their products contribute significantly to areas such as minimally invasive surgery, infection prevention, and orthopedic solutions.

Commitment to Quality and Innovation

The company prides itself on providing medical device manufacturers with reliable, innovative solutions that meet stringent regulatory standards. With a comprehensive understanding of the medical device supply chain, UFP Technologies positions itself as a crucial partner in enhancing patient safety and care. Their expertise in crafting single-use devices underscores their dedication to improving health outcomes globally.

Contact Information for Inquiries

For any inquiries regarding the upcoming financial results or the company’s operations, stakeholders may reach out to:

Ron Lataille
Sr. Vice President, Treasurer, and CFO
Phone: (978) 234-0926
Email: rlataille@ufpt.com

Investor Relations Contacts

Investors seeking additional details can contact:
Jeff Elliott or Phillip Kupper
Three Part Advisors
Phone: (214) 966-9014 or (817) 778-8339
Website: www.threepa.com

Frequently Asked Questions

What are the key dates for UFP Technologies’ financial results?

The company will release its second quarter financial results on August 4, 2025, followed by a conference call on August 5, 2025, at 8:30 AM Eastern Time.

How can I access the conference call?

Participants can join the call by dialing 1-888-243-4451 for toll-free access or 1-412-542-4135 for international calls.

Where can I find the webcast of the conference call?

The live webcast and subsequent replay will be available on UFP Technologies’ Investor Relations site.

What is UFP Technologies’ primary business focus?

UFP Technologies specializes in the contract development and manufacturing of single-use and single-patient medical devices.

If I have further questions, whom should I contact?

You can contact Ron Lataille, Sr. Vice President, at (978) 234-0926, or email him at rlataille@ufpt.com.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.